Immune Therapeutics, Inc.

$0.09-7.00%($-0.01)
TickerSpark Score
41/100
Weak
100
Valuation
40
Profitability
15
Growth
20
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMUN research report →

52-Week Range2% of range
Low $0.07
Current $0.09
High $1.30

Companywww.immunetherapeutics.com

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc.

CEO
Noreen M. Griffin
IPO
2010
HQ
Winter Park, FL, US

Price Chart

-93.70% · this period
$1.27$0.67$0.06Nov 08May 11Nov 13

Valuation

Market Cap
$7.78M
P/E
-0.00
P/S
0.00
P/B
-0.00
EV/EBITDA
-0.52
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
67.11%
ROIC
43.69%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-5,788,000 · -261.41%
EPS
$-0.16 · -102.16%
Op Income
$-1,163,000
FCF YoY
-366.87%

Performance & Tape

52W High
$1.30
52W Low
$0.07
50D MA
$0.20
200D MA
$0.48
Beta
0.26
Avg Volume
13.34K

Get TickerSpark's AI analysis on IMUN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Feb 10, 23Farmer Glen Abuy409,000
Jul 25, 22H. Louis Salomonsky Jr. Revocable Trustother0
Jul 25, 22Salomonsky Henry Louisother0
Jul 25, 22Salomonsky Henry Louisother0
Aug 2, 22Farmer Glen Aother0
Aug 2, 22Farmer Glen Aother0
Jun 30, 17Wilson Kelly O'Brienother500
Jul 25, 22Wilson Kelly O'Brienother0
Jul 25, 22Wilson Kelly O'Brienother0
Jul 25, 22Wilson Kelly O'Brienother0

Our IMUN Coverage

We haven't published any research on IMUN yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate IMUN Report →

Similar Companies